Although lncRNAs are one of the lowest-abundance cfRNAs in circulation, MALAT-1 is detectable in serum and may complement biomarker panels to improve NSCLC patient diagnosis and prognosis [130]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.